This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Wyatt Technology Corporation, doing business as Wyatt Technology Corp. The contract, valued at $105,825.50, is for the delivery of Wyatt's UDAWN MALS W/ OPTILAB UTREX and WYATT QELS instrumentation, which are used for the characterization of macromolecules and nanoparticles. This equipment supports critical research efforts in areas like vaccine development, macromolecular and nanoparticle analysis, and formulation analysis. The contract does not have a set-aside designation. Wyatt Technology Corp is a leading provider of specialized analytical instrumentation, equipment, and services to various federal agencies, including HHS, USDA, Commerce, VA, and EPA.